First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes von Aronson, Ronnie, Abitbol, Alexander, Tweden, Katherine S.

Volltext

Two-Year Outcomes of Vagal Nerve Blocking (vBloc) for the Treatment of Obesity in the ReCharge Trial von Apovian, Caroline M., Shah, Sajani N., Wolfe, Bruce M., Ikramuddin, Sayeed, Miller, Christopher J., Tweden, Katherine S., Billington, Charles J., Shikora, Scott A.

Volltext

979-P: Glycemic Improvements in CGM-Naïve Patients during SMBG and Implantable CGM Use von TWEDEN, KATHERINE S., ROMAROWSKI, BEN, MDINGI, COLLEEN, KAUFMAN, FRANCINE R.

Volltext

Real-World Safety of an Implantable Continuous Glucose Sensor Over Multiple Cycles of Use: A Post-Market Registry Study von Deiss, Dorothee, Irace, Concetta, Carlson, Grace, Tweden, Katherine S, Kaufman, Francine R

Volltext

A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study von Christiansen, Mark P, Klaff, Leslie J, Bailey, Timothy S, Brazg, Ron, Carlson, Grace, Tweden, Katherine S

Volltext

Intra-abdominal vagal blocking (VBLOC therapy): Clinical results with a new implantable medical device von Camilleri, M., MD, Toouli, J., MD, PhD, Herrera, M.F., MD, Kulseng, B., MD, PhD, Kow, L., MD, PhD, Pantoja, J.P., MD, Marvik, R., MD, PhD, Johnsen, G., MD, Billington, C.J., MD, Moody, F.G., MD, Knudson, M.B., PhD, Tweden, K.S., PhD, Vollmer, M., BA, Wilson, R.R., MD, Anvari, M., MD, PhD

Volltext

994-P: Real-World Evaluation of the Implantable 180-Day Eversense E3 CGM System von Tweden, Katherine S, Romarowski, Ben, Mdingi, Colleen, Kaufman, Francine R

Volltext

Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor von Sanchez, Patricia, Ghosh-Dastidar, Samanwoy, Tweden, Katherine S, Kaufman, Francine R

Volltext

Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study von Garg, Satish K, Liljenquist, David, Bode, Bruce, Christiansen, Mark P, Bailey, Timothy S, Brazg, Ronald L, Denham, Douglas S, Chang, Anna R, Akturk, Halis Kaan, Dehennis, Andrew, Tweden, Katherine S, Kaufman, Francine R

Volltext

656-P: Effect of Calibration Frequency on Accuracy of a 180-Day Implantable CGM System von JACQUIN, ARNAUD E., AL-KHAWI, LUJAIN, GHOSH-DASTIDAR, SAMANWOY, TWEDEN, KATHERINE S., KAUFMAN, FRANCINE R.

Volltext

655-P: Evaluation of Accuracy and Longevity of an Implantable CGM System through 365 Days von JACQUIN, ARNAUD E., AL-KHAWI, LUJAIN, SANCHEZ, PATRICIA, MOHANTY, SANAT, TWEDEN, KATHERINE S., KAUFMAN, FRANCINE R.

Volltext

Effect of Reversible Intermittent Intra-abdominal Vagal Nerve Blockade on Morbid Obesity: The ReCharge Randomized Clinical Trial von Ikramuddin, Sayeed, Blackstone, Robin P, Brancatisano, Anthony, Toouli, James, Shah, Sajani N, Wolfe, Bruce M, Fujioka, Ken, Maher, James W, Swain, James, Que, Florencia G, Morton, John M, Leslie, Daniel B, Brancatisano, Roy, Kow, Lilian, O’Rourke, Robert W, Deveney, Clifford, Takata, Mark, Miller, Christopher J, Knudson, Mark B, Tweden, Katherine S, Shikora, Scott A, Sarr, Michael G, Billington, Charles J

Volltext

976-P: Post Market Clinical Follow-Up (PMCF) Registry to Demonstrate the Long Term Safety of the Eversense CGM System von CARLSON, GRACE, TWEDEN, KATHERINE S., MDINGI, COLLEEN, HARIDAS, HARITHA

Volltext

356-OR: Accuracy Evaluation of an Implantable CGM with Chemistry Improvements in a 365-Day Feasibility Study von AL-KHAWI, LUJAIN, SANCHEZ, PATRICIA, HUFFSTETLER, PHILIP, VELVADAPU, VENKATA N., MASCIOTTI, JAMES M., TWEDEN, KATHERINE S., KAUFMAN, FRANCINE R.

Volltext

Sustained Weight Loss with Vagal Nerve Blockade but Not with Sham: 18-Month Results of the ReCharge Trial von Tweden, K. S., Sarr, Michael G., Billington, C. J., Miller, Christopher J., Ikramuddin, Sayeed, Gibbons, Robert D., Sarwer, David B., Anvari, Mehran, Apovian, Caroline M., Wolfe, Bruce, Shikora, S., Knudson, M. B.

Volltext

691-P: Evaluation of an Implantable CGM System Using a Multiple-Analyte Indicator Hydrogel for Calibration Reduction von VELVADAPU, VENKATA N., MASCIOTTI, JAMES M., DEHENNIS, ANDREW D., SANCHEZ, PATRICIA, TWEDEN, KATHERINE S., KAUFMAN, FRANCINE R., IOACARA, SORIN

Volltext

Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles von Tweden, Katherine S, Deiss, Dorothee, Rastogi, Ravi, Addaguduru, Suresh, Kaufman, Francine R

Volltext

Clinical use of a 180‐day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes von Irace, Concetta, Cutruzzolà, Antonio, Nuzzi, Annamaria, Assaloni, Roberta, Brunato, Barbara, Pitocco, Dario, Tartaglione, Linda, Di Molfetta, Sergio, Cignarelli, Angelo, Laviola, Luigi, Citro, Giuseppe, Lovati, Elisabetta, Gnasso, Agostino, Tweden, Katherine S, Kaufman, Francine R

Volltext

Vagal Blocking Improves Glycemic Control and Elevated Blood Pressure in Obese Subjects with Type 2 Diabetes Mellitus von Pantoja, J. P., Johnsen, G., Brancatisano, A., Tweden, K. S., Knudson, M. B., Billington, C. J., Shikora, S., Kow, L., Brancatisano, R., Zulewski, H., Toouli, J., Herrera, M. F., Kulseng, Bård

Volltext

878-P: Real-World Data from U.S. Patients Using a Long-Term Implantable Continuous Glucose Monitoring (CGM) System: Age Effect on Glycemic Control von TWEDEN, KATHERINE, GHOSH-DASTIDAR, SAMANWOY, DEHENNIS, ANDREW D., KAUFMAN, FRANCINE

Volltext